Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/GENO stock hub

STO/GENO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/GENOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3B

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/GENO

In the news

Latest news · STO/GENO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E43.6

P25 n/aP50 n/aP75 n/a

Trailing P/E54.7

P25 n/aP50 n/aP75 n/a

ROE9.5

P25 n/aP50 n/aP75 n/a

ROIC12.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/GENO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

SEK

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	36
Employees Change	4%
Employees Change Percent	12.5
Enterprise value	SEK 1.2B
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0002485979
Last refreshed	2026-05-10
Market cap	SEK 1.3B
Price	SEK 20.15
Price currency	SEK
Rev Per Employee	3,641,416.67x
Sector	Healthcare
Sic	2836
Symbol	sto/GENO
Website	https://www.genovis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.83%
EV Earnings	50.75x
EV/EBIT	40.03x
EV/EBITDA	27.94x
EV/FCF	34.16x
EV/Sales	9.41x
FCF yield	2.71%
Forward P/E	43.57x
P/B ratio	4.8x
P/E ratio	54.67x
P/S ratio	10.15x
PE Ratio10 Y	171.63x
PE Ratio3 Y	62.94x
PE Ratio5 Y	106.61x
PEG ratio	26.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.35%
EBITDA Margin	23.36%
FCF margin	27.54%
Gross margin	89.1%
Gross Profit	SEK 116.8M
Gross Profit Growth	8.28%
Gross Profit Growth Q	2.32%
Gross Profit Growth3 Y	-2.63%
Gross Profit Growth5 Y	13.51%
Net Income	SEK 24.3M
Net Income Growth	2.83%
Net Income Growth Q	23.18%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	-16.96%
Net Income Growth5 Y	21.65%
Pretax Margin	20%
Profit Margin	18.54%
Profit Per Employee	SEK 674,972
Profitable Years	7
ROA	4.22
Roa5y	8.82
ROCE	6.79
ROE	9.53
Roe5y	19.59
ROIC	12.36
Roic5y	33.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	28.13%
Cagr15y	9.72%
Cagr1y	-12.4%
Cagr3y	-31.68%
Cagr5y	-14.4%
EPS Growth	2.11
EPS Growth Q	22.07
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	-17.16
EPS Growth5 Y	21.47
FCF Growth	24.83%
FCF Growth Q	53.17%
FCF Growth3 Y	-5.55%
FCF Growth5 Y	39.35%
OCF Growth	27.64%
OCF Growth Q	55%
OCF Growth3 Y	-6.97%
OCF Growth5 Y	33.98%
Revenue Growth	5.83x
Revenue Growth Q	3.55x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.69x
Revenue Growth5 Y	14.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.37
Assets	SEK 381.9M
Cash	SEK 170.9M
Current Assets	SEK 212.8M
Current Liabilities	SEK 27.8M
Debt	SEK 73M
Debt EBITDA	SEK 1.95
Debt Equity	SEK 0.26
Debt FCF	SEK 2.02
Equity	SEK 277.4M
Interest Coverage	6.08
Liabilities	SEK 104.6M
Long Term Assets	SEK 169.1M
Long Term Liabilities	SEK 76.7M
Net Cash	SEK 97.9M
Net Cash By Market Cap	SEK 7.36
Net Cash Growth	-1.93%
Net Debt EBITDA	SEK -3.2
Net Debt Equity	SEK -0.35
Net Debt FCF	SEK -2.71
Tangible Book Value	SEK 198.6M
Tangible Book Value Per Share	SEK 3.01
WACC	13.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.65
Net Working Capital	SEK 22M
Quick ratio	6.14
Working Capital	SEK 185M
Working Capital Turnover	SEK 0.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,091.92%
1Y total return	-12.39%
200-day SMA	21.28
3Y total return	-68.12%
50-day SMA	18.32
50-day SMA vs 200-day SMA	50under200
5Y total return	-54.05%
All Time High	318
All Time High Change	-93.66%
All Time High Date	2006-09-25
All Time Low	1.26
All Time Low Change	1,499.21%
All Time Low Date	2016-06-01
ATR	0.77
Beta	1.7
Beta1y	0.73
Beta2y	0.84
Ch YTD	-5.18
High	20.65
High52	29.8
High52 Date	2025-07-04
High52ch	-32.38%
Low	19.98
Low52	15.64
Low52 Date	2026-03-23
Low52ch	28.84%
Ma50ch	9.98%
Price vs 200-day SMA	-5.31%
RSI	56.96
RSI Monthly	42.15
RSI Weekly	50.38
Sharpe ratio	-0.29x
Sortino ratio	-0.27
Total Return	-0.71%
Tr YTD	-5.18
Tr15y	302.03%
Tr1m	5.72%
Tr1w	1.26%
Tr3m	-1.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK 24.1M
Operating Income Growth	0.38
Operating Income Growth Q	-41.38
Operating Income Growth3 Y	-20.04
Operating Income Growth5 Y	23.96
Operating margin	18.35

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	55,208,629%
Net Borrowing	-572,000
Shares Insiders	16.43%
Shares Institutions	30.71%
Shares Out	66,062,792
Shares Qo Q	0%
Shares Yo Y	0.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK 36.1M
Average Volume	60,904.6x
Bv Per Share	4.2
CAPEX	SEK -1.8M
Ch10y	1,025.7
Ch15y	172.3
Ch1m	5.72
Ch1w	1.26
Ch1y	-12.39
Ch3m	-1.47
Ch3y	-68.12
Ch5y	-54.05
Ch6m	-4.28
Change	-2.18%
Change From Open	-2.42
Close	20.6
Days Gap	0.24
Depreciation Amortization	6,559,000
Dollar Volume	247,965.9
Earnings Date	2026-04-23
EBIT	SEK 24.1M
EBITDA	SEK 30.6M
EPS	SEK 0.37
F Score	5
FCF	SEK 36.1M
FCF EV Yield	2.93x
FCF Per Share	SEK 0.55
Financing CF	11,572,000
Fiscal Year End	December
Founded	1,999
Graham Number	5.90046
Graham Upside	-70.72
Income Tax	SEK 1.9M
Investing CF	-53,929,000
Is Primary Listing	1
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Last Split Date	2012-04-04
Last Split Type	Reverse
Lynch Fair Value	SEK 7.98
Lynch Upside	-60.41
Ma150	20.11
Ma150ch	0.2%
Ma20	19.97
Ma20ch	0.89%
Net CF	-4,476,000
Next Earnings Date	2026-07-23
Open	20.65
P FCF Ratio	36.87
P OCF Ratio	35.14
Position In Range	25.37
Ppne	81,676,000
Price Date	2026-05-08
Price EBITDA	SEK 43.48
Ptbv Ratio	6.7
Relative Volume	0.2x
Revenue	131,091,000x
Tax By Revenue	1.46x
Tax Rate	7.32%
Tr6m	-4.28%
Volume	12,306

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/GENO pay a dividend?

Capital-return profile for this ticker.

Performance

STO/GENO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/GENO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+30.7%

Share of float held by funds and institutions

Insider ownership

+16.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.7%

Negative means the company is buying back shares.

Technical

STO/GENO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.0

Neutral momentum band

Price vs 200-day MA

-5.3%

50/200-day relationship not available

Beta (5Y)

1.70

More volatile than the market

Sharpe ratio

-0.29

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/GENO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/GENO stock rating?

sto/GENO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/GENO analysis?

The full report lives at /stocks/sto/GENO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/GENO?

The latest report frames sto/GENO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/GENO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.